As the U.S. IPO market opens back up, here’s how biotech CEO Marc de Garidel says business leaders can capitalize.
But how does a company actually go public—and what does a CEO need to do to adapt their leadership style in the aftermath?
To learn more, Inc. spoke with Marc de Garidel, CEO of the publicly-traded biotech company Abivax, which focuses on developing … [4057 chars]
Source: Inc. Magazine | Published: 2025-10-15T15:17:08Z
Credit: Inc. Magazine
